Skip to content

Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Stapled Antimesenteric Functional End-to-end Anastomosis (Kono-S) Versus Stapled Antimesenteric Isoperistaltic Side-to-side Anastomosis for the Postoperative Recurrence of Crohn's Disease: a Randomized Control Trial Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05658081
Enrollment
236
Registered
2022-12-20
Start date
2022-12-08
Completion date
2029-12-31
Last updated
2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Recurrence

Brief summary

The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.

Interventions

PROCEDUREKono-S group

patients in this arm will receive stapled Kono-S anastomosis after bowel resection

PROCEDURESide-to-side group

patients in this arm will receive stapled antimesenteric isoperistaltic side-to-side anastomosis after bowel resection

Sponsors

Jinling Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients with Crohn's disease needing bowel resection and anastomosis; * ileocolic anastomosis; * written consent acquired

Exclusion criteria

* patients underwent enterostomy; * small bowel anastomosis; * anticipating other trial.

Design outcomes

Primary

MeasureTime frameDescription
the endoscopic recurrence rate at 1 year after surgeryat 1 year after surgery(6-18month)the endoscopic recurrence rate at 1 year after surgery

Secondary

MeasureTime frameDescription
the clinical recurrence rate at 1 and 5 year after surgery1 and 5 year after surgerythe clinical recurrence rate at 1 and 5 year after surgery
the surgical recurrence rate at 1 and 5 year after surgery1 and 5 year after surgerythe surgical recurrence rate at 1 and 5 year after surgery
the endoscopic recurrence rate at 1 year after surgery1 and 5 year after surgerythe endoscopic recurrence rate at 1 year after surgery
quality of life for CD patients inflammatory bowel disease questionnaire(IBDQ)1 and 5 year after surgeryIBDQ , higher means better,IBDQ,7-224;
quality of life for CD patients Short Form 121 and 5 year after surgeryShort Form 12 , higher means better,Short Form-12, 0-12;

Countries

China

Contacts

Primary Contactming duan, M.D.
duanming1206@126.com+86-025-80860036

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026